... with thrombosis. In particular, among SLE patients, these antibodies mean a high risk of thrombosis only in a small subset, sharing clinical features with primary antiphospholipid syndrome. As laboratory examination is still unable to distinguish between high-risk and non-high-risk antiphospholipid antibodies...

...Domingo Hernández; Maria Luisa Dominguez; Francisco Diaz; Maria Luisa Fernandez; Victor Lorenzo; Aurelio Rodriguez; Armando Torres Systemic lupus erythematosus (SLE) patients, specially those with antiphospholipid antibodies, have a high incidence of arterial and venous thrombotic manifestations...

...M. Perdiguero; M. Boronat; P. Marco; F. Rivera Although several clinical and morphological changes observed in overt systemic lupus erythematosus have been associated with the presence of antiphospholipid antibodies (aPL), the relation between these antibodies and lupus nephropathy (LN...

... the literature we found several observations of paraneoplastic scleroderma, and in other series cases of scleroderma-linked (and in rare instances cancer-linked) antiphospholipid autoantibodies. Search for antiphospholipid antibodies should be considered in patients with systemic scleroderma as well...

... usually presents with a large spectrum of signs and symptoms, we observed several patients who presented with pulmonary and renal involvement, thus mimicking a systemic vasculitis. Since the prognosis of the antiphospholipid antibody syndrome may be serious and the therapeutic measures differ from those...